期刊文献+

不同方式治疗鼻咽癌的远期疗效分析

Analysis of Long Term Results of Different Treatment for Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的 :回顾性分析比较不同方式治疗鼻咽癌患者的远期疗效 ,并分析其它相关因素对其预后的影响。方法 :从 1988年 1月至 1996年 3月共收治住院 895例首程根治鼻咽癌患者。根据不同的治疗方法 ,分为常规放疗组、腔内放疗组、超分割放疗组和同期放化疗组。结果 :(1)本组病例总的 5年生存率为 5 0 6 4 % ,总的 10年生存率为 2 3 .2 9% ;其中常规组、腔内组、超分割组和同期放化疗组的 5年总生存率分别为 4 7. 33%、5 2. 6 7%、5 8. 82 %和 5 8 .85 % (P <0. 0 5 )。 (2 )Ⅰ、Ⅱ、Ⅲ、Ⅳ期病例的 5年总生存率分别为 88 89%、76 88%、5 6 . 6 7%和 31 .95 % (P <0 0 0 0 1)。 (3)局部控制率分别为 :常规组 83 95 %、腔内组 89. 4 0 %、超分割组 92. 4 5 %和放化疗组 96 . 0 6 %。 (4)用多因素逐步回归分析 ,N分期对生存率的影响最大 (P <0. 0 0 0 1) :不同的放疗方式及T分期对生存率亦有影响 (P <0 .0 5 ) ;加用化疗能提高生存率 (P <0 . 0 1)。结论 :采用不同的放疗方式 ,对生存率及局控率有影响 ;根治性放射治疗联合同期化疗对于N分期晚的鼻咽癌的远期疗效似有提高的趋势。 Objective:To retrospectively analyze and compare the long term results about the treatment for nasopharyngeal carcinoma by different methods and other prognostic factors.Methods:895 cases of nasopharyngeal carcinoma were treated from January 1988 to March 1996.Patients were divided in 4 groups which included conventional radiotherapy group(CRT),high dose rate brychetherapy irradiation group (HDR),hyperfractionated radiotherapy group(HFRT) and concurrent chemotherapy combined radiotherapy group(CHRT).Results:(1)The overall 5-year survival rates of the entire group was 50.64%,and 10-year survival rate was 23.29%.The total 5-year survival rate were 47.33% for CRT,52.67% for HDR,58.82% for HFRT and 58.85% for CHRT,respectively(P<0.05).(2)The 5-year survival rates for Ⅰ,Ⅱ,Ⅲ and Ⅳ stage were 88.89%,76.88%,56.67% and 31.95% respectively(P<0.0001).(3)The local control rate were 83.95% for CRT,89.40% for HDR,92.45% for HFRT and 96.06% for CHRT respectively.(4)The cox regression analysis showed that N staging had most prognostic effect on survival(P<0.05);survival was increased by combination with chemotherapy(P<0.01).Conclusion:Different radiotherapy methods may influence the survival and local control rates;radiotherapy combined with concurrent chemotherapy tend to improve the long term response of nasopharyngeal carcinoma,especially for patients with advanced N staging.
出处 《四川肿瘤防治》 2005年第1期12-14,共3页 Sichuan Journal of Cancer Control
关键词 鼻咽肿瘤 放射治疗 化学治疗 分割方式 鼻咽癌 Nasopharyngeal Neoplasms/Radiotherapy Nasopharyngeal Neoplasms/Chemotherapy Fractionation Prognosis.
  • 相关文献

参考文献13

  • 1张宜勤,魏宝清.20年来鼻咽癌放射治疗疗效全面提高的原因分析[J].中华放射肿瘤学杂志,1999,8(2):73-76. 被引量:78
  • 2Chen KY,Fletcher GH.Malignant trmors of the nasopharynx[J] .Radiology 1971,99:165-171.
  • 3Hoppe RT,Goffinet DR,Bagshaw MA.Carcinoma of the nasopharynx:Eighteen years'experience with megavoltage radiation therapy[J]. Cancer 1976,37: 2605-2612.
  • 4Moench HC, Phillips TL. Carcinoma of the nasopharynx:Review of 146 patients with emphasis on radiation dose and time factors [ J]. Am JSurg1972,124:515-518.
  • 5Wang DC,Cai WM,Hu YH,et al. Long-term survival of 1035 cases of nasopharvnageal carcinoma[ J]. Cancer 1988,61: 2338-2341.
  • 6Chatain M,Teshima T,Inoue T,et al. Radiation therapy for nasopharyngeal carcinoma: Retrospective review of 105 patients based on a survey of Kansai Cancer Therapist Group [J]. Carcer 1986,57:2267-2271.
  • 7Dimery IW,Legha SS,Peters LJ,et al. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma[J]. Cancer 1987,60:943-949.
  • 8Geara FB,Glisson BS,Sanguineti G,et al. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced Nasopharyngeal carcinoma [ J ]. Cancer, 1997, 79 ( 7 ): 1279-1286.
  • 9Lee AWM. Alter fractionation for Nasopharyngeal carcinoma benefits and harms [A] .UICC NPC Workshop [C] ,2003:50.
  • 10International Nasopharynx Cancer Study Group. VUMCA I trial preliminary results of a randomized trial comparing neoadjuvant chemotherapy ( cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage Ⅳ ( ≥ N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival[ J]. Int J Raditat Oncol Biol Phys, 1996,35(3) :463-469.

二级参考文献4

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部